TSE:AKU Akumin (AKU) Stock Price, News & Analysis → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free AKU Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$0.44▼C$0.5352-Week Range N/AVolume12,903 shsAverage Volume7,202 shsMarket CapitalizationC$37.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlines Get Akumin alerts: Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. About Akumin Stock (TSE:AKU)Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. On October 22, 2023, Akumin Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.Read More Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. AKU Stock News HeadlinesMay 29, 2024 | theglobeandmail.comHealwell AI: Top 10 Undervalued Healthcare Sector Stocks on TSX (AIDX)May 29, 2024 | theglobeandmail.comBriaCell Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX (BCT)May 29, 2024 | theglobeandmail.comBausch Health Companies: Top 10 Undervalued Healthcare Sector Stocks on TSX (BHC)April 18, 2024 | fool.caTSX Health Care SectorMarch 27, 2024 | finance.yahoo.comAkumin Inc. (AKU.TO)February 15, 2024 | msn.comCyber-attack shuts down access to off-site radiology services for some Allina sites, other healthcare groupsFebruary 8, 2024 | finance.yahoo.comAkumin Announces Changes to Leadership TeamJanuary 5, 2024 | ft.comRising rates and costs push up US healthcare bankruptciesJanuary 4, 2024 | bizjournals.comCFO abruptly resigns from multimillion-dollar public health care firm amid bankruptcyDecember 29, 2023 | finance.yahoo.comAKUMIN ANNOUNCES LEADERSHIP TRANSITIONDecember 15, 2023 | msn.comAkumin Inc. GAAP EPS of -C$0.90, revenue of C$180.62MDecember 1, 2023 | morningstar.comAkumin Inc Ordinary SharesNovember 3, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - AKUNovember 1, 2023 | msn.comA lesson from a hacked healthcare provider: Keep track of your medical historyOctober 24, 2023 | msn.comPatients desperate for imaging services, worried about health information, after Akumin shuts down due to ransomware attackOctober 23, 2023 | markets.businessinsider.comCrude Oil Falls Sharply; Apollomics Shares PlungeOctober 23, 2023 | benzinga.comDow Falls Over 100 Points; Chicago Fed National Activity Index Increases In SeptemberOctober 20, 2023 | finance.yahoo.comAkumin Inc. Reaches Agreement with Stonepeak to Become a Private CompanyAugust 9, 2023 | finance.yahoo.comAkumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special CommitteeAugust 8, 2023 | finance.yahoo.comAkumin to Host Second Quarter 2023 Financial Results Call on August 10, 2023July 6, 2023 | markets.businessinsider.comWhy Is Akumin (AKU) Stock Up 31% Today?May 23, 2023 | theglobeandmail.comClosing Bell: Akumin Inc down on Friday (AKU)May 12, 2023 | msn.comWhy Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day SessionMay 12, 2023 | uk.finance.yahoo.comAkumin First Quarter 2023 Earnings: US$0.39 loss per share (vs US$0.35 loss in 1Q 2022)May 9, 2023 | markets.businessinsider.comGlassbeam appoints Rhonda Longmore-Grund as ChairmanSee More Headlines Receive AKU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolTSE:AKU CUSIPN/A CIKN/A Webwww.akumin.com Phone416-613-1391FaxN/AEmployees1,527Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($3.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-255,800,000.00 Net Margins-34.67% Pretax MarginN/A Return on Equity-483.86% Return on Assets0.47% Debt Debt-to-Equity Ratio266,886.35 Current Ratio0.12 Quick Ratio1.03 Sales & Book Value Annual SalesC$737.69 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.96 Book ValueC($2.86) per share Price / BookN/AMiscellaneous Outstanding Shares70,180,000Free FloatN/AMarket CapC$37.20 million OptionableNot Optionable Beta0.15 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Riadh Zine-El-Abidine (Age 52)Chairman & CEO Comp: $2.4MMr. Krishna Kumar AnanthasubramanianPresident & COOMr. Ronald J. Bienias (Age 52)Interim CFO & Chief Restructuring Officer Mr. Paul Nelis (Age 56)Chief Information Officer Darren SpeedChief Compliance OfficerMs. Tracy Wiese (Age 55)Chief Strategy & Marketing Officer Ms. Holly Huso (Age 59)Enterprise Sales Officer Ms. Laurie R. Miller (Age 57)Chief Human Resources Officer Mr. Mohammad SaleemSenior Vice President of Financial ReportingMr. Christopher FitzgeraldChief Revenue OfficerMore ExecutivesKey CompetitorsSpectral MedicalTSE:EDTGeneNewsTSE:GENLED Medical DiagnosticsCVE:LMDLexaGeneCVE:LXGSQI DiagnosticsCVE:SQDView All Competitors AKU Stock Analysis - Frequently Asked Questions Should I buy or sell Akumin stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AKU shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKU, but not buy additional shares or sell existing shares. View AKU analyst ratings or view top-rated stocks. What other stocks do shareholders of Akumin own? Based on aggregate information from My MarketBeat watchlists, some companies that other Akumin investors own include AltaGas (ALA), Alimentation Couche-Tard (ATD.B), Brookfield Property Partners (BPY.UN), Cargojet (CJT), Canadian National Railway (CNR), Dollarama (DOL), Enbridge (ENB), Héroux-Devtek (HRX) and Inter Pipeline (IPL). How do I buy shares of Akumin? Shares of AKU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:AKU) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akumin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.